Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001916:Brachial Artery; D016122:Brachiocephalic Trunk; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002343:Carotid Artery, Internal; D002404:Catheterization; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D007269:Injections, Intra-Arterial; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D008722:Methods; D008727:Methotrexate / Q000008:administration & dosage; D009062:Mouth Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D012516:Osteosarcoma / Q000188:drug therapy; D010255:Paranasal Sinus Neoplasms / Q000188:drug therapy; D010610:Pharyngeal Neoplasms / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy; D012888:Skull Neoplasms / Q000188:drug therapy; D014747:Vinblastine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D003609:Dactinomycin; D014747:Vinblastine; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate